Literature DB >> 8695805

Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection.

M Clerici1, C Balotta, A Salvaggio, C Riva, D Trabattoni, L Papagno, A Berlusconi, S Rusconi, M L Villa, M Moroni, M Galli.   

Abstract

Human immunodeficiency virus (HIV) isolability, rate of viral replication, HIV phenotype, type 1 and type 2 cytokine production, and CD4 counts were cross sectionally analyzed in 63 HIV seropositive (HIV+) individuals to establish possible correlations between virologic and immunologic markers of protection and progression. We observed that these markers are tightly correlated. Thus, lack or low prevalence of HIV isolability and the presence of nonsyncitium inducing strains are associated with the strongest type 1 cytokine production, the weakest type 2 cytokine production, and highest CD4 counts. Conversely, the isolation of highly replicating, syncitium-inducing HIV strains is associated with the weakest type 1 cytokine production, the strongest type 2 cytokine production, and lowest CD4 counts. Additionally, it was determined that the interleukin (IL)-10/IL-2 ratio best discriminates among different virologic scenarios. These data suggest that the virologic and immunologic correlates of disease protection and progression might be associated variables that define two different subsets of HIV+ individuals and lend support to a viro-immunologic hypothesis of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695805

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.

Authors:  P Brazille; N Dereuddre-Bosquet; C Leport; P Clayette; O Boyer; J-L Vildé; D Dormont; O Benveniste
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

2.  Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity.

Authors:  Noelle D Brodeur; Juliet V Spencer
Journal:  Virus Res       Date:  2010-08-20       Impact factor: 3.303

Review 3.  Common threads in persistent viral infections.

Authors:  Melissa Kane; Tatyana Golovkina
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

4.  Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection.

Authors:  Elias A Said; Franck P Dupuy; Lydie Trautmann; Yuwei Zhang; Yu Shi; Mohamed El-Far; Brenna J Hill; Alessandra Noto; Petronela Ancuta; Yoav Peretz; Simone G Fonseca; Julien Van Grevenynghe; Mohamed R Boulassel; Julie Bruneau; Naglaa H Shoukry; Jean-Pierre Routy; Daniel C Douek; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

5.  Imbalance in cytokine production by whole blood related to presence of cytopathogenic HIV-1 strains in HIV-1-infected patients.

Authors:  S Benyoucef; G Lion; Y Gérard; P Wattré; D De Groote; D Hober
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

6.  Interleukin-10 determines viral clearance or persistence in vivo.

Authors:  David G Brooks; Matthew J Trifilo; Kurt H Edelmann; Luc Teyton; Dorian B McGavern; Michael B A Oldstone
Journal:  Nat Med       Date:  2006-10-15       Impact factor: 53.440

7.  Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.

Authors:  P De Paoli; S Zanussi; C Simonelli; M T Bortolin; M D'Andrea; C Crepaldi; R Talamini; M Comar; M Giacca; U Tirelli
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 8.  The role of IL-10 in regulating immunity to persistent viral infections.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

9.  Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission.

Authors:  B K Patterson; A Landay; J Andersson; C Brown; H Behbahani; D Jiyamapa; Z Burki; D Stanislawski; M A Czerniewski; P Garcia
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

10.  IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells.

Authors:  Mark A Brockman; Douglas S Kwon; Daniel P Tighe; David F Pavlik; Pamela C Rosato; Jennifer Sela; Filippos Porichis; Sylvie Le Gall; Michael T Waring; Kristin Moss; Heiko Jessen; Florencia Pereyra; Daniel G Kavanagh; Bruce D Walker; Daniel E Kaufmann
Journal:  Blood       Date:  2009-04-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.